Key stats
About Y-BIOLOGICS
Sector
Industry
Headquarters
Daejeon
Website
Founded
2007
ISIN
KR7338840002
FIGI
BBG01JPDHD40
Y-Biologics, Inc. operates as a biopharmaceutical company. It engages in the research and development of antibody therapeutics. The firm’s products include Ymax ABL, a human antibody library and ALiCE, a novel format for bispecific T-cell engager antibodies. The company was founded in 2007 and is headquartered in Daejeon, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 338840 is 9530 KRW — it has decreased by 0.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange Y-BIOLOGICS stocks are traded under the ticker 338840.
338840 stock is 2.44% volatile and has beta coefficient of 1.25. Check out the list of the most volatile stocks — is Y-BIOLOGICS there?
338840 stock has risen by 1.71% compared to the previous week, the month change is a 21.11% fall, over the last year Y-BIOLOGICS has showed a 59.36% decrease.
No, 338840 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 338840 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Y-BIOLOGICS stock right from TradingView charts — choose your broker and connect to your account.